More Business Wire

View Older Stories View Newer Stories

Nov 18, 2024 08:00AM Director of United States Patent and Trademark Office Kathi Vidal to Rejoin Winston & Strawn
Nov 18, 2024 08:00AM Matica Biotechnology Appoints Life Sciences Leader Min Park, MBA to Chief Commercial Officer
Nov 18, 2024 08:00AM TurnOnGreen Awarded Electric Vehicle Charging Contract for the Livermore Valley Joint Unified School District in Livermore, California
Nov 18, 2024 08:00AM Seismic Therapeutic Presents New Preclinical Data for S-4321, a Next Generation PD‑1:FcγRIIb-Selective Bifunctional Agonist Antibody for the Treatment of Autoimmune Disease, at ACR Convergence 2024
Nov 18, 2024 08:00AM Know Labs Provides Overview of FY2024 10-K Annual Report
Nov 18, 2024 08:00AM 2025 Nissan Armada Delivers Full-Size Adventures From $56,520
Nov 18, 2024 08:00AM LBMX Named Canada’s Top 100 Employer
Nov 18, 2024 08:00AM Stonepeak Acquires Fleet Companies
Nov 18, 2024 08:00AM KaliVir Immunotherapeutics Strengthens Innovation Portfolio with Issuance of Three New U.S. Patents Covering Its VET™ Product Candidates
Nov 18, 2024 08:00AM NICE Is A 2024 Gartner® Peer Insights™ CCaaS Customers’ Choice —Only Vendor to Receive This Recognition for the 2nd Time
Nov 18, 2024 08:00AM APAC Customer Enhances Border Security with Over $10M Investment in Cognyte Solutions
Nov 18, 2024 08:00AM A10 Networks to Participate in Upcoming Investor Conferences
Nov 18, 2024 08:00AM Kohl’s Gifts More Than $500,000 to Local Nonprofits Through Hometown Giving Program This Holiday Season
Nov 18, 2024 08:00AM City National Entertainment CEO Kelly Coffey Joins Operation HOPE Global Board of Advisors
Nov 18, 2024 08:00AM DoorDash Encourages Canadians To Celebrate HoliDifferently, Revealing Unique Holiday Preferences
Nov 18, 2024 08:00AM Lumentum Announces Upcoming Investor Events
Nov 18, 2024 08:00AM CarbonFree Launches World’s First Zero-Carbon Mineral Designed to Reduce Carbon Footprint in Wide Range of Products
Nov 18, 2024 08:00AM Restaurant Owner Turned Startup Founder Launches Free AI Tool to Help California Small Businesses Meet Critical Federal Deadline
Nov 18, 2024 08:00AM Blackhawk Network (BHN) and Mastercard Announce Global Environmental Sustainability Initiative
Nov 18, 2024 08:00AM Churchill’s Anne Philpott Named to WSJ Pro Private Equity’s 2024 Women To Watch List
Nov 18, 2024 08:00AM Cotiviti to Launch End-to-End Healthcare Fraud Solution at 2024 NHCAA Annual Training Conference
Nov 18, 2024 08:00AM DigitalOwl Announces Strategic Collaboration with ExamOne to Improve Record Retrieval and Analysis
Nov 18, 2024 08:00AM ReCode Therapeutics Announces Additional Funding From the Cystic Fibrosis Foundation to Accelerate Development of Novel Gene Correction Therapeutics to Treat Cystic Fibrosis
Nov 18, 2024 08:00AM Esperanto Technologies and NEC Cooperate on Initiative to Advance Next Generation RISC-V Chips and Software Solutions for HPC
Nov 18, 2024 08:00AM AMP to Operate Waste Connections Recycling Facility with AI-Powered Sortation Technology
Nov 18, 2024 08:00AM Avenacy Announces Launch of Dexmedetomidine Injection, USP in the U.S. Market
Nov 18, 2024 08:00AM BridgeBio Oncology Therapeutics (BBOT) Appoints Praveen Tipirneni, MD, to its Board of Directors as Non-Executive Director
Nov 18, 2024 08:00AM Chrysalis BioTherapeutics, Inc. Announces Collaboration with NIAID to Evaluate Chrysalin® for the Treatment of Cutaneous Radiation Injury
Nov 18, 2024 07:48AM Media Release: Following a year of elections held worldwide, Allianz launches global “Power of Unity” program to reinforce the strength of common ground
Nov 18, 2024 07:45AM Take Control of Your Heart Health: No-Cost Health Screenings Including Lp(a) Testing Offered in Clarkston by Care Access
Nov 18, 2024 07:43AM Deluxe Announces Senior Secured Notes Offering
Nov 18, 2024 07:35AM DocGo Announces Participation at Three Upcoming Investor Conferences
Nov 18, 2024 07:31AM Arrowhead Pharmaceuticals Submits New Drug Application to U.S. FDA for Plozasiran for the Treatment of Familial Chylomicronemia Syndrome
Nov 18, 2024 07:30AM Arrowhead Pharmaceuticals Presents New Data at AHA24 from PALISADE Phase 3 Study and Open-Label Extension from MUIR and SHASTA-2 Studies of Plozasiran
Nov 18, 2024 07:30AM Almonty Industries Inc. Appoints Fernando Vitorino as Chief Operating Officer of Almonty Korea Tungsten Corp. (“AKTC”)
Nov 18, 2024 07:30AM Vertiv Hosts Investor Event and Announces Quarterly Dividend
Nov 18, 2024 07:30AM Capstan Therapeutics Presents Preclinical Data on Lead In Vivo CAR-T Candidate, CPTX2309, at American College of Rheumatology (ACR) Convergence 2024
Nov 18, 2024 07:30AM Odyssey Investment Partners Sells NSI Industries
Nov 18, 2024 07:30AM Generate Capital Welcomes Harsi Thethi as Interim CFO, Recognizing Brian Lehman’s Impact
Nov 18, 2024 07:15AM Twist Bioscience Announces Fiscal 2024 Fourth Quarter and Full Year Financial Results
Nov 18, 2024 07:05AM SkyWater Announces Participation in 13th Annual NYC Summit
Nov 18, 2024 07:01AM Pacific Defense Announces Expansion of Manufacturing and Design Engineering Center in Sunnyvale, CA to Meet Growing Global Demand
Nov 18, 2024 07:01AM Kinaxis Launches Supply Chain Orchestration Maturity Model and Self-Assessment
Nov 18, 2024 07:01AM FiscalNote Announces Generative AI Distribution Partnership With AI Search Engine ProRata.ai to License FiscalNote’s Award-Winning, Trusted Content
Nov 18, 2024 07:01AM Advyzon Announces Auria, New Product Offering for Family Offices and UHNW Clients
Nov 18, 2024 07:00AM Aldeyra Therapeutics Announces FDA Acceptance for Review of Reproxalap New Drug Application for the Treatment of Dry Eye Disease, Expands AbbVie Option Agreement
Nov 18, 2024 07:00AM Deluxe Announces Inducement Grant for Kimberly Cross
Nov 18, 2024 07:00AM CI Global Asset Management Announces Mutual Fund and ETF Mergers and a Risk Rating Change
Nov 18, 2024 07:00AM SBC Medical Group Holdings Announces Definitive Agreement to Acquire, Aesthetic Healthcare Holdings Pte. Ltd, a Multi-Unit Owner of Aesthetic Treatment Clinics in Singapore
Nov 18, 2024 07:00AM Alentis Receives FDA Fast Track Designation for ALE.P02 for the Treatment of CLDN1+ Squamous Solid Tumors
View Newer Stories View Older Stories